HEARTLAND Protocol

HEARTLAND Protocol FHIR Implementation Guide
0.3.0 - United States of America flag

HEARTLAND FHIR candidate 0.3.0 — draft, experimental R4 4.0.1 reference. Prepared for technical review; not evidence of clinical validation or vendor interoperability.

CodeSystem: HEARTLAND Evidence Level (Experimental)

Official URL: https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level Version: 0.3.0
Draft as of 2026-09-29 Computable Name: HeartlandEvidenceLevel

Copyright/Legal: CC-BY 4.0

Three-tiered transparency labels distinguishing evidence strength behind HEARTLAND Protocol v3.2 recommendations, helping clinicians calibrate clinical decisions.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level defines the following codes:

CodeDisplayDefinition
established Established Evidence Interventions with strong guideline support, such as SGLT2i for all HF phenotypes endorsed by the 2022 AHA/ACC/HFSA guideline.
emerging Emerging Evidence Recent trial findings not yet fully incorporated into guidelines, such as finerenone for HFpEF based on the FINEARTS-HF trial.
pragmatic Pragmatic Heuristic Tools developed for clinical utility without formal statistical validation, such as the HEARTLAND Risk Score itself.

Description of the above table(s).